Table 3. Association of genetic risk score and SAD risk in the testing set.
# of subjects (SAD/Controls) | Mean GRS | Median GRS | |||||
---|---|---|---|---|---|---|---|
Sample set | SAD | Controls | SAD | Controls | P value | AUC | |
GRS based on 6 SNPs | 227/378 | 2.48 | 1.15 | 0.85 | 0.55 | <0.001 | 0.63 |
APOE ε4 carriers | 93/81 | 4.57 | 2.47 | 2.51 | 1.69 | 0.003 | 0.64 |
APOE ε4 non-carriers | 134/297 | 1.03 | 0.79 | 0.53 | 0.47 | 0.101 | 0.55 |
Modified GRS based on 3 non APOE-related SNPs | 227/378 | 1.02 | 0.91 | 0.87 | 0.87 | 0.002 | 0.58 |
APOE ε4 carriers | 93/81 | 1.01 | 0.92 | 0.87 | 0.87 | 0.187 | 0.56 |
APOE ε4 non-carriers | 134/297 | 1.02 | 0.91 | 0.87 | 0.87 | 0.006 | 0.58 |
Abbreviation: SAD, sporadic Alzheimer's disease; GRS, genetic risk score